Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases
Most chronic liver diseases (CLDs) are characterized by inflammatory processes with aberrant expressions of various pro- and anti-inflammatory mediators in the liver. These mediators are the driving force of many inflammatory liver disorders, which often result in fibrosis, cirrhosis, and liver tumo...
Saved in:
Main Authors: | Ting Liu (Author), Yu Zhou (Author), Kwang Suk Ko (Author), Heping Yang (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors
by: Zhen Li, et al.
Published: (2013) -
Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy
by: Yihui Zhou, et al.
Published: (2021) -
Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy
by: Yihui Zhou, et al.
Published: (2021) -
Transcriptional activation of the Myc gene by glucose in β-cells requires a ChREBP-dependent 3-D chromatin interaction between the Myc and Pvt1 genes
by: Liora S. Katz, et al.
Published: (2024) -
Hypomethylation of the c-myc promoter region induced by phenobarbital in rat liver
by: Katarzyna Urbanek-Olejnik, et al.
Published: (2018)